Definiens, ACD to develop RNA biomarker assays

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Advanced Cell Diagnostics (ACD), and Definiens have partnered to develop image analysis applications that will enable researchers to quantify RNA molecules in routine clinical specimens.

The partnership will build on ACD’s RNAscope platform and add new specialized image analysis solutions that will process and analyze images from RNAscope assays.

ACD’s RNAscope is an RNA in situ hybridization (ISH) method that can detect and quantify any expressed gene at single molecule sensitivity in individual cells in all major biological specimen types, said the Hayward, Calif. based company.

ACD will demonstrate the technology at American Association for Cancer Research (AACR) conference in Orlando, Fla., April 3 to 6.